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Abstract 
 Empty nose syndrome is a complication of nasal surgery wherein patients develop a 
persistent, debilitating sense of nasal obstruction and dyspnea despite clear nasal cavities. It is 
characterized by a discrepancy between prominent subjective symptoms and near total lack of 
objective findings, making it difficult to diagnose. The pathophysiology of empty nose syndrome 
is a complex mix of aerodynamic, physiologic, and neurological changes leading to altered 
airflow and diminished sensory function. Evolving treatment options consist of medical 
symptom control or surgical reconstruction. 
Introduction 
Empty nose syndrome (ENS), first described in 1994 by Kern and Stenkvist, is a 
secondary form of atrophic rhinitis seen as a complication of sinonasal surgery. While ENS is 
considered rare, the incidence is unknown and some have suggested that it may be as high as 
20%.1 ENS is generally seen following turbinate resection—most commonly the inferior 
turbinate—but has also been reported following less destructive procedures such as submucosal 
cautery, laser therapy, and turbinate-sparing operations.2,3 Although few patients develop ENS 
following nasal surgery, it remains greatly feared due to its debilitating effect on quality of life. 
In this review, we explore recent advances in the understanding and treatment of ENS. 
Presentation and Diagnosis 
The diagnosis of ENS is challenging given the paucity of objective findings and the 
characteristic discrepancy between patients’ subjective symptoms and clinician’s findings on 
exam. Symptoms may begin months to years following nasal surgery and are categorized as 
nasal or extra-nasal symptoms.4 The common nasal symptoms are a paradoxical sense of nasal 
obstruction—where the nasal cavities are widely patent but the patient reports severe 
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obstruction—nasal dryness and crusting, malodor from the nasal cavity, anosmia, mucopurulent 
rhinorrhea, and a persistent sense of dyspnea.3 Extra-nasal symptoms include facial pain, 
headaches, sleep disturbances and psychological issues such as: fatigue, irritability, anger, 
anxiety and depression.3,5 Perhaps the most debilitating psychological symptom is aprosexia 
nasalis: a chronic impairment of one’s ability to concentrate due to extreme preoccupation with 
maintaining the sensation of nasal patency.3 Although there is no predictive correlation between 
extent of surgery and occurrence of ENS, one study found that smaller residual turbinate volume 
was associated with increased severity of nasal symptoms.6 
Given the lack of objective indicators, the diagnosis remains one of exclusion—based 
upon the patient’s history. Currently, the main tool to assist in the diagnosis of ENS is the Sino-
nasal Outcome Test-25 (SNOT-25) questionnaire. A recent six item ENS-specific questionnaire 
(ENS6Q) has also been shown to accurately differentiate ENS patients and to correlate with 
SNOT scores.7  
Several objective findings have been proposed for use in distinguishing ENS from other 
causes of nasal dryness and perceived obstruction. The first is the placement of a saline-soaked 
cotton ball within the nasal cavity. Alleviation of symptoms within 20-30 minutes supports the 
diagnosis of ENS and predicts a favorable response to surgery.2 Most recently Thamboo et al 
have proposed that patients with ENS have characteristically thicker central and posterior septal 
mucosa on CT when compared to control patients and patients with a history of inferior turbinate 
resection but no symptoms of ENS.8 Additionally, they found that ENS patients had thicker nasal 
floor mucosa compared to control patients, but not patients having turbinate resection without 
ENS.8 Until these tests are further validated though, the mainstays of diagnosis remain clinical 
history and the SNOT questionnaire.  
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Pathophysiology 
The mechanisms underlying ENS are complex and not yet fully elucidated. Current 
evidence suggests that anatomic changes from nasal surgery alter aerodynamics, pulmonary 
function, mucosal physiology, and CNS function to cause the aggregation of symptoms in ENS. 
Turbinate resection alters airflow patterns through the nasal cavity. Decreased airflow 
velocity leads to reduced stimulation of nasal mechanoreceptors, likely contributing to the 
sensation of obstruction.9 Subsequent decreases in shear stress along the mucosa lead to areas of 
higher temperature, with reduced activation of cool-sensing thermoreceptors—also important in 
the sense of nasal airflow and patency.3,9 Loss of laminar airflow increases water vapor removal, 
likely contributing to increased nasal dryness.9 Turbinate removal also moves airflow away from 
olfactory areas, decreasing sense of smell.9  
Removal of the turbinates also decreases nasal resistance, which is known to be an 
important factor in opening peripheral bronchioles in the lungs.4,9-11 Decreased lung aeration may 
explain the persistent dyspnea felt by ENS patients. Interestingly, changes in nasal aerodynamics 
were more prominent following inferior turbinate resection, except for increased airflow velocity 
around the sphenopalatine ganglion seen more with middle turbinate removal.9 This may explain 
why ENS is more common with inferior turbinate surgery and why headache—thought to be due 
to sphenopalatine ganglion irritation—occurs most in ENS due to middle turbinate resection.9 
Nasal surgery also modifies nasal mucosal physiology. Loss of glandular surface area 
contributes to decreased air humidification and is more prominent following inferior turbinate 
resection as the middle turbinate has smaller surface area and a lower density of erectile 
tissue.3,4,10 Removal of mucosa also destroys sensory nerves, most notably the trigeminal cool 
thermoreceptor—TRPM8.3,10 Dayal et al  showed that aggregate stimulation of nasal TRPM8 
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thermoreceptors is important in generating sensation of airflow and thus, loss of receptor 
containing mucosa may contribute to the paradoxical sense of nasal obstruction in ENS.10 
A still poorly explained feature of ENS is the alteration in CNS activation seen on fMRI. 
Increased temporal, cerebellar and amygdala activation, as well as marked limbic reactivity have 
been noted in patients with ENS, which may explain the common psychological symptoms.1,4,5 
Treatment 
 The mainstays of ENS treatment are prevention via minimally invasive nasal surgery and 
medical management with mucosal humidification, nasal irrigation, emollient application and 
even nasal lubricants with menthol—to increase activation of remaining TRPM8 receptors.2-4 For 
those refractory to medical care, surgical recreation of turbinate mass becomes the goal. If 
enough turbinate mass remains this can be through reconstruction, otherwise augmentation of the 
lateral wall, septum, or floor is performed.3,11 Medialization of remaining turbinate mass has 
been trialed, but has shown minimal results and has a risk of lacrimal duct obstruction.4  
 Many options for turbinate reconstruction have been evaluated and while it is difficult to 
accurately assess outcomes given the small sample size, some have shown promise. One review 
demonstrated that ENS symptoms improved post-surgery regardless of implant type.12 Cartilage 
autograft has been assessed by multiple studies and has shown improvement in symptoms.13,14 
Costal cartilage appears to be superior to conchal cartilage given its better volume and ability to 
be shaped.14 Medpor implants have also shown benefit in both subjective and objective measures 
and have been suggested given that their porous nature promotes fibrovascularization of the 
implant.15,16 Acellular dermal grafts may be beneficial given their immunologic inertness and 
have been shown to be equal to silastic inserts for resolving symptoms;11 however, they may 
undergo some shrinkage and resorption, requiring further augmentation.17 -Tricalcium 
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phosphate has also been tried, due to its compact, porous structure and slow resorption rate.17,18 
Xenograft transplant of porcine small intestine has also had good results, with minimal 
resorption, in a recent series.19 
 Injections have also been proposed for turbinate reconstruction. Hydroxyappetite and 
hyaluronic acid have been used, but have issues with excessive resorption requiring additional 
injections or procedures.12,15 Recently, Xu et al described excellent results after trialing injection 
of autologous adipose-derived stem cells based upon the benefits of potential for differentiation 
into epithelial like cells, easy access, and low immunogenicity.20 
Although most research on ENS treatment has focused on medical and surgical options, 
recently, Legmone et al have suggested that ENS patients should be managed as if they have a 
somatic symptom disorder.1 This is predicated on similarities in extra-nasal ENS features to 
somatic symptom disorders and the evidence of abnormal neurologic function. It has been 
reported that treatment with cognitive therapy and an SSRI/SNRI dramatically improved patient 
function, although ENS specific symptoms did not decrease.1,5 
Conclusion 
 Empty nose syndrome is a complex condition the is difficult to anticipate and diagnose. 
ENS develops following nasal surgery due to alterations in nasal anatomy that affect airflow 
dynamics, mucosal physiology, and possibly even neurologic function. Although prevention is 
the best option, turbinate sparing procedures do not ensure that ENS will not develop and thus 
medical control and surgical reconstruction remain the most common treatment. 
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